These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
232 related items for PubMed ID: 7508417
1. Liposome-entrapped T-cell peptide provides help for a co-entrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory. Gregoriadis G, Wang Z, Barenholz Y, Francis MJ. Immunology; 1993 Dec; 80(4):535-40. PubMed ID: 7508417 [Abstract] [Full Text] [Related]
2. Peptide-induced memory (IgG) response, cross-reactive with native proteins, requires covalent linkage of a specific B cell epitope with a T cell epitope. Zegers ND, van Holten C, Claasen E, Boersma WJ. Eur J Immunol; 1993 Mar; 23(3):630-4. PubMed ID: 7680611 [Abstract] [Full Text] [Related]
3. Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. I. T cell fine specificity. Milich DR, Hughes JL, McLachlan A, Langley KE, Thornton GB, Jones JE. J Immunol; 1990 May 01; 144(9):3535-43. PubMed ID: 1691762 [Abstract] [Full Text] [Related]
4. Potentiation of immune response against the RESA peptides of Plasmodium falciparum by incorporating a universal T-cell epitope (CS.T3) and an immunomodulator (polytuftsin), and delivery through liposomes. Kumar P, Biswas S, Rao DN. Microbiol Immunol; 1999 May 01; 43(6):567-76. PubMed ID: 10480553 [Abstract] [Full Text] [Related]
5. Induction of a cytotoxic T cell response by co-injection of a T helper peptide and a cytotoxic T lymphocyte peptide in incomplete Freund's adjuvant (IFA): further enhancement by pre-injection of IFA alone. Valmori D, Romero JF, Men Y, Maryanski JL, Romero P, Corradin G. Eur J Immunol; 1994 Jun 01; 24(6):1458-62. PubMed ID: 7515816 [Abstract] [Full Text] [Related]
6. Liposomes as immunological adjuvants in eliciting antibodies specific to the synthetic polypeptide poly(LTyr, LGlu)-poly(DLAla)--(LLys) with high frequency of site-associated idiotypic determinants. Lifshitz R, Gitler C, Mozes E. Eur J Immunol; 1981 May 01; 11(5):398-404. PubMed ID: 7262180 [Abstract] [Full Text] [Related]
7. Design of highly immunogenic liposomal constructs combining structurally independent B cell and T helper cell peptide epitopes. Boeckler C, Dautel D, Schelté P, Frisch B, Wachsmann D, Klein JP, Schuber F. Eur J Immunol; 1999 Jul 01; 29(7):2297-308. PubMed ID: 10427993 [Abstract] [Full Text] [Related]
8. Immunogenicity and vaccine efficacy of synthetic peptides containing Semliki Forest virus B and T cell epitopes. Snijders A, Benaissa-Trouw BJ, Snippe H, Kraaijeveld CA. J Gen Virol; 1992 Sep 01; 73 ( Pt 9)():2267-72. PubMed ID: 1383405 [Abstract] [Full Text] [Related]
9. A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2), and S regions of HBsAg. Milich DR, McLachlan A, Moriarty A, Thornton GB. J Immunol; 1987 Jun 15; 138(12):4457-65. PubMed ID: 2438344 [Abstract] [Full Text] [Related]
10. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses. Guan HH, Budzynski W, Koganty RR, Krantz MJ, Reddish MA, Rogers JA, Longenecker BM, Samuel J. Bioconjug Chem; 1998 Jun 15; 9(4):451-8. PubMed ID: 9667946 [Abstract] [Full Text] [Related]
11. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity. Kaumaya PT, Kobs-Conrad S, Seo YH, Lee H, VanBuskirk AM, Feng N, Sheridan JF, Stevens V. J Mol Recognit; 1993 Jun 15; 6(2):81-94. PubMed ID: 7508238 [Abstract] [Full Text] [Related]
12. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides. Franke ED, Corradin G, Hoffman SL. J Immunol; 1997 Oct 01; 159(7):3424-33. PubMed ID: 9317141 [Abstract] [Full Text] [Related]
13. Parameters affecting the immunogenicity of a liposome-associated synthetic hexapeptide antigen. Frisch B, Muller S, Briand JP, Van Regenmortel MH, Schuber F. Eur J Immunol; 1991 Jan 01; 21(1):185-93. PubMed ID: 1703962 [Abstract] [Full Text] [Related]
14. Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus. Fernández IM, Snijders A, Benaissa-Trouw BJ, Harmsen M, Snippe H, Kraaijeveld CA. J Virol; 1993 Oct 01; 67(10):5843-8. PubMed ID: 7690411 [Abstract] [Full Text] [Related]
15. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120. Greenstein JL, Schad VC, Goodwin WH, Brauer AB, Bollinger BK, Chin RD, Kuo MC. J Immunol; 1992 Jun 15; 148(12):3970-7. PubMed ID: 1376346 [Abstract] [Full Text] [Related]
16. Importance of subtype in the immune response to the pre-S(2) region of the hepatitis B surface antigen. II. Synthetic Pre-S(2) immunogen. Milich DR, Jones JE, McLachlan A, Bitter G, Moriarty A, Hughes JL. J Immunol; 1990 May 01; 144(9):3544-51. PubMed ID: 1691763 [Abstract] [Full Text] [Related]
17. Identification of Mengo virus T helper cell epitopes. Muir S, Kobasa D, Bittle J, Scraba D. J Gen Virol; 1994 Nov 01; 75 ( Pt 11)():2925-36. PubMed ID: 7525861 [Abstract] [Full Text] [Related]
18. Enhanced immunogenicity of a sequence derived from hepatitis B virus surface antigen in a composite peptide that includes the immunostimulatory region from human interleukin 1. Rao KV, Nayak AR. Proc Natl Acad Sci U S A; 1990 Jul 01; 87(14):5519-22. PubMed ID: 2371286 [Abstract] [Full Text] [Related]